| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant endocrine therapy with tamoxifen: side-effects on the female genital tract are not always what they seem
|
Mourits, M.J.
|
|
|
23 |
11 |
p. 2990
|
article
|
| 2 |
Adjuvant therapy in primary GIST: state-of-the-art
|
Reichardt, P.
|
|
|
23 |
11 |
p. 2776-2781
|
article
|
| 3 |
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis
|
Tramacere, I.
|
|
|
23 |
11 |
p. 2791-2798
|
article
|
| 4 |
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
|
Ilie, M.
|
|
|
23 |
11 |
p. 2907-2913
|
article
|
| 5 |
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting
|
Goto, K.
|
|
|
23 |
11 |
p. 2914-2919
|
article
|
| 6 |
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?
|
Mezynski, J.
|
|
|
23 |
11 |
p. 2943-2947
|
article
|
| 7 |
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study
|
Reyners, A.K.L.
|
|
|
23 |
11 |
p. 2896-2902
|
article
|
| 8 |
A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer
|
Han, J.Y.
|
|
|
23 |
11 |
p. 2925-2930
|
article
|
| 9 |
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
|
Kindler, H.L.
|
|
|
23 |
11 |
p. 2834-2842
|
article
|
| 10 |
Attributable causes of cancer in China
|
Wang, J.B.
|
|
|
23 |
11 |
p. 2983-2989
|
article
|
| 11 |
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
|
Gonçalves, A.
|
|
|
23 |
11 |
p. 2799-2805
|
article
|
| 12 |
Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1–pT3 bladder tumors
|
Koning,, C.C.E.
|
|
|
23 |
11 |
p. 2948-2953
|
article
|
| 13 |
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
|
Hiltermann, T.J.N.
|
|
|
23 |
11 |
p. 2937-2942
|
article
|
| 14 |
Clinical outcome for EML4-ALK-positive patients with advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy
|
Takeda, M.
|
|
|
23 |
11 |
p. 2931-2936
|
article
|
| 15 |
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma
|
Sasse, S.
|
|
|
23 |
11 |
p. 2953-2959
|
article
|
| 16 |
Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods
|
Seruga, B.
|
|
|
23 |
11 |
p. 2977-2982
|
article
|
| 17 |
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen
|
Prat, A.
|
|
|
23 |
11 |
p. 2866-2873
|
article
|
| 18 |
Editorial board
|
|
|
|
23 |
11 |
p. ii-iii
|
article
|
| 19 |
Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer
|
Truin, W.
|
|
|
23 |
11 |
p. 2859-2865
|
article
|
| 20 |
Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs
|
Naing, A.
|
|
|
23 |
11 |
p. 2960-2963
|
article
|
| 21 |
Explanatory factors of sexual function in sexual minority women breast cancer survivors
|
Boehmer, U.
|
|
|
23 |
11 |
p. 2873-2878
|
article
|
| 22 |
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer
|
Thiery-Vuillemin, A.
|
|
|
23 |
11 |
p. 2992-2993
|
article
|
| 23 |
Hope: oncology's missing breakthrough
|
Corn, Benjamin W.
|
|
|
23 |
11 |
p. 2775
|
article
|
| 24 |
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy
|
Lybol, C.
|
|
|
23 |
11 |
p. 2903-2906
|
article
|
| 25 |
Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands
|
van Steenbergen, L.N.
|
|
|
23 |
11 |
p. 2805-2811
|
article
|
| 26 |
Lobular endocervical glandular hyperplasia and peritoneal pigmentation associated with Peutz–Jeghers syndrome due to a germline mutation of STK11
|
Hirasawa, A.
|
|
|
23 |
11 |
p. 2990-2992
|
article
|
| 27 |
Meat consumption and cancer risk: is the definition of red meat always suitable?
|
Lippi, G.
|
|
|
23 |
11 |
p. 2993-2994
|
article
|
| 28 |
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma
|
Pipas, J.M.
|
|
|
23 |
11 |
p. 2820-2827
|
article
|
| 29 |
Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases
|
Munzone, E.
|
|
|
23 |
11 |
p. 2884-2890
|
article
|
| 30 |
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)
|
Duell, E.J.
|
|
|
23 |
11 |
p. 2964-2970
|
article
|
| 31 |
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
|
Karlsson, P.
|
|
|
23 |
11 |
p. 2852-2858
|
article
|
| 32 |
Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) †
|
Thuss-Patience, P.C.
|
|
|
23 |
11 |
p. 2827-2834
|
article
|
| 33 |
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
|
Kluger, N.
|
|
|
23 |
11 |
p. 2879-2884
|
article
|
| 34 |
Post-cancer fatigue is not associated with immune activation or altered cytokine production
|
Cameron, B.A.
|
|
|
23 |
11 |
p. 2890-2895
|
article
|
| 35 |
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
|
Luksch, R.
|
|
|
23 |
11 |
p. 2970-2976
|
article
|
| 36 |
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
|
Huober, J.
|
|
|
23 |
11 |
p. 2843-2851
|
article
|
| 37 |
Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled Analysis
|
Schild, S.E.
|
|
|
23 |
11 |
p. 2919-2924
|
article
|
| 38 |
Table of Contents
|
|
|
|
23 |
11 |
p. iv-vi
|
article
|
| 39 |
The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis
|
Hadji, P.
|
|
|
23 |
11 |
p. 2782-2790
|
article
|
| 40 |
VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA
|
Martin, L.K.
|
|
|
23 |
11 |
p. 2812-2820
|
article
|
Journal description